vs
Orthofix Medical Inc.（OFIX）与PERDOCEO EDUCATION Corp（PRDO）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是PERDOCEO EDUCATION Corp的1.0倍（$219.9M vs $211.6M），PERDOCEO EDUCATION Corp同比增速更快（20.0% vs 2.0%），PERDOCEO EDUCATION Corp自由现金流更多（$37.9M vs $16.8M），过去两年PERDOCEO EDUCATION Corp的营收复合增速更高（12.2% vs 8.0%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
Perdoceo Education是美国上市营利性教育集团，前身为职业教育公司（Career Education Corporation），旗下运营五所美国营利性大学，包括美国洲际大学、科罗拉多理工大学、南加利福尼亚大学、三叉戟国际大学及圣奥古斯丁健康科学大学，业务覆盖高等教育、职业教育及健康科学相关教育领域。
OFIX vs PRDO — 直观对比
营收规模更大
OFIX
是对方的1.0倍
$211.6M
营收增速更快
PRDO
高出18.0%
2.0%
自由现金流更多
PRDO
多$21.1M
$16.8M
两年增速更快
PRDO
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $211.6M |
| 净利润 | $-2.2M | — |
| 毛利率 | 71.1% | — |
| 营业利润率 | 0.2% | 19.8% |
| 净利率 | -1.0% | — |
| 营收同比 | 2.0% | 20.0% |
| 净利润同比 | 92.4% | — |
| 每股收益（稀释后） | $-0.05 | $0.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXPRDO
| Q4 25 | $219.9M | $211.6M | ||
| Q3 25 | $205.6M | $211.9M | ||
| Q2 25 | $203.1M | $209.6M | ||
| Q1 25 | $193.6M | $213.0M | ||
| Q4 24 | $215.7M | $176.4M | ||
| Q3 24 | $196.6M | $169.8M | ||
| Q2 24 | $198.6M | $166.7M | ||
| Q1 24 | $188.6M | $168.3M |
净利润OFIXPRDO
| Q4 25 | $-2.2M | — | ||
| Q3 25 | $-22.8M | $39.9M | ||
| Q2 25 | $-14.1M | $41.0M | ||
| Q1 25 | $-53.1M | $43.7M | ||
| Q4 24 | $-29.1M | — | ||
| Q3 24 | $-27.4M | $38.3M | ||
| Q2 24 | $-33.4M | $38.4M | ||
| Q1 24 | $-36.0M | $39.4M |
毛利率OFIXPRDO
| Q4 25 | 71.1% | — | ||
| Q3 25 | 72.2% | — | ||
| Q2 25 | 68.7% | — | ||
| Q1 25 | 62.8% | — | ||
| Q4 24 | 69.0% | — | ||
| Q3 24 | 68.7% | — | ||
| Q2 24 | 67.8% | — | ||
| Q1 24 | 67.5% | — |
营业利润率OFIXPRDO
| Q4 25 | 0.2% | 19.8% | ||
| Q3 25 | -8.3% | 24.1% | ||
| Q2 25 | -7.9% | 24.5% | ||
| Q1 25 | -25.2% | 24.3% | ||
| Q4 24 | -5.3% | 21.1% | ||
| Q3 24 | -9.6% | 26.4% | ||
| Q2 24 | -12.5% | 27.6% | ||
| Q1 24 | -15.6% | 27.5% |
净利率OFIXPRDO
| Q4 25 | -1.0% | — | ||
| Q3 25 | -11.1% | 18.8% | ||
| Q2 25 | -6.9% | 19.6% | ||
| Q1 25 | -27.4% | 20.5% | ||
| Q4 24 | -13.5% | — | ||
| Q3 24 | -13.9% | 22.5% | ||
| Q2 24 | -16.8% | 23.0% | ||
| Q1 24 | -19.1% | 23.4% |
每股收益（稀释后）OFIXPRDO
| Q4 25 | $-0.05 | $0.55 | ||
| Q3 25 | $-0.57 | $0.60 | ||
| Q2 25 | $-0.36 | $0.62 | ||
| Q1 25 | $-1.35 | $0.65 | ||
| Q4 24 | $-0.76 | $0.46 | ||
| Q3 24 | $-0.71 | $0.57 | ||
| Q2 24 | $-0.88 | $0.57 | ||
| Q1 24 | $-0.95 | $0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $111.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $450.0M | $972.4M |
| 总资产 | $850.6M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OFIXPRDO
| Q4 25 | $82.0M | $111.0M | ||
| Q3 25 | $62.9M | $159.5M | ||
| Q2 25 | $65.6M | $172.1M | ||
| Q1 25 | $58.0M | $132.1M | ||
| Q4 24 | $83.2M | $109.1M | ||
| Q3 24 | $30.1M | $238.0M | ||
| Q2 24 | $26.4M | $127.9M | ||
| Q1 24 | $27.0M | $125.8M |
总债务OFIXPRDO
| Q4 25 | — | — | ||
| Q3 25 | $157.2M | — | ||
| Q2 25 | $157.0M | — | ||
| Q1 25 | $156.9M | — | ||
| Q4 24 | $157.0M | — | ||
| Q3 24 | $118.5M | — | ||
| Q2 24 | $118.0M | — | ||
| Q1 24 | $118.2M | — |
股东权益OFIXPRDO
| Q4 25 | $450.0M | $972.4M | ||
| Q3 25 | $442.5M | $997.9M | ||
| Q2 25 | $458.3M | $984.6M | ||
| Q1 25 | $458.3M | $970.3M | ||
| Q4 24 | $503.1M | $959.5M | ||
| Q3 24 | $525.9M | $935.4M | ||
| Q2 24 | $546.0M | $899.5M | ||
| Q1 24 | $570.3M | $866.1M |
总资产OFIXPRDO
| Q4 25 | $850.6M | $1.2B | ||
| Q3 25 | $832.6M | $1.3B | ||
| Q2 25 | $837.2M | $1.3B | ||
| Q1 25 | $823.1M | $1.3B | ||
| Q4 24 | $893.3M | $1.2B | ||
| Q3 24 | $867.9M | $1.1B | ||
| Q2 24 | $882.0M | $1.1B | ||
| Q1 24 | $906.0M | $1.1B |
负债/权益比OFIXPRDO
| Q4 25 | — | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.23× | — | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $40.1M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $37.9M |
| 自由现金流率自由现金流/营收 | 7.6% | 17.9% |
| 资本支出强度资本支出/营收 | 4.9% | 1.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $216.7M |
8季度趋势，按日历期对齐
经营现金流OFIXPRDO
| Q4 25 | $27.7M | $40.1M | ||
| Q3 25 | $12.4M | $41.2M | ||
| Q2 25 | $11.6M | $78.8M | ||
| Q1 25 | $-18.4M | $65.1M | ||
| Q4 24 | $23.7M | $17.6M | ||
| Q3 24 | $11.7M | $51.0M | ||
| Q2 24 | $9.0M | $38.5M | ||
| Q1 24 | $-18.6M | $54.5M |
自由现金流OFIXPRDO
| Q4 25 | $16.8M | $37.9M | ||
| Q3 25 | $2.5M | $39.4M | ||
| Q2 25 | $4.5M | $76.0M | ||
| Q1 25 | $-25.1M | $63.4M | ||
| Q4 24 | $15.2M | $16.0M | ||
| Q3 24 | $6.3M | $50.0M | ||
| Q2 24 | $-360.0K | $37.7M | ||
| Q1 24 | $-29.1M | $53.3M |
自由现金流率OFIXPRDO
| Q4 25 | 7.6% | 17.9% | ||
| Q3 25 | 1.2% | 18.6% | ||
| Q2 25 | 2.2% | 36.3% | ||
| Q1 25 | -13.0% | 29.8% | ||
| Q4 24 | 7.0% | 9.1% | ||
| Q3 24 | 3.2% | 29.4% | ||
| Q2 24 | -0.2% | 22.6% | ||
| Q1 24 | -15.4% | 31.7% |
资本支出强度OFIXPRDO
| Q4 25 | 4.9% | 1.1% | ||
| Q3 25 | 4.8% | 0.9% | ||
| Q2 25 | 3.5% | 1.3% | ||
| Q1 25 | 3.5% | 0.8% | ||
| Q4 24 | 4.0% | 0.9% | ||
| Q3 24 | 2.7% | 0.6% | ||
| Q2 24 | 4.7% | 0.5% | ||
| Q1 24 | 5.6% | 0.7% |
现金转化率OFIXPRDO
| Q4 25 | — | — | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 1.49× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.33× | ||
| Q2 24 | — | 1.00× | ||
| Q1 24 | — | 1.38× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
PRDO
| CTU | $107.0M | 51% |
| AIUS | $60.8M | 29% |
| University Of St Augustine For Health Sciences Llc | $43.7M | 21% |
| Other | $1.1M | 1% |
